Why Regeneron Pharmaceuticals Stock Is Bolting Higher Today
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a large-cap biotech company, are on fire today. The stock is up by a handsome 15.1% as of 11:52 a.m. EDT Tuesday.
The spark? Before the opening bell, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from genetically modified mice, as well as from humans who have recovered from COVID-19, in an effort to build a preventive cocktail treatment against the deadly respiratory disease.
Image source: Getty Images.
Source Fool.com
